Global Motor Neurone Disease (MND) Market, By Type (Amyotrophic lateral sclerosis (ALS), Progressive bulbar palsy (PBP), Progressive muscular atrophy (PMA), Primary lateral sclerosis (PLS)), Treatment (Medication, Physiotherapy, Palliative Care, Others), Diagnosis (Blood Tests, Electromyography (EMG), MRI Scan, Transcranial magnetic stimulation (TMS), Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), Symptoms (Muscle Wasting, Muscle Weakness, Fasciculations, Speech Problems, Swallowing Problems and Excessive Saliva, Cramps and Muscle Spasms, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Motor Neurone Disease (MND) Market
Motor neurone disease (MND) market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 7.0% in the above mentioned forecast period.
Motor neurone disease (MND) is a rare neurological disorder which occurs due to the degeneration of motor system. In this condition, nerve cells that control the muscles that enable us to move, swallow, speak, and breathe undergo degeneration and eventually die. This condition is characterized by muscle wasting, muscle weakness, fasciculations, speech problems, swallowing problems and excessive saliva, cramps, and muscle spasms.
The rise in the prevalence of motor neurone disease and growing geriatric population are the major factors influencing the market growth rate. Furthermore, growing demand for effective and advanced treatment, rising healthcare expenditure, growing government funding and rising initiatives by public and private organisations to spread awareness about the rare disease and its available treatment are the factors that will expand the motor neurone disease (MND) market.
Rise in the research and development activities and ongoing clinical trials will provide beneficial opportunities for the motor neurone disease (MND) market in the forecast period of 2021-2028.
However, high cost of treatment and side effects associated with the medication are the factors that will hinder the market growth. In the forecast period mentioned above, lack of cure and less awareness will further challenge the motor neurone disease (MND) market.
This motor neurone disease (MND) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the motor neurone disease (MND) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Motor Neurone Disease (MND) Market Scope and Market Size
The motor neurone disease (MND) market is segmented on the basis of type, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the motor neurone disease (MND) market is segmented into amyotrophic lateral sclerosis (ALS), progressive bulbar palsy (PBP), progressive muscular atrophy (PMA) and primary lateral sclerosis (PLS).
- On the basis of treatment, the motor neurone disease (MND) market is segmented into medication, physiotherapy, palliative care and others. Medication has been further sub-segmented into riluzole, anticonvulsants, antidepressants, muscle relaxants and nonsteroidal anti-inflammatory drugs. Muscle relaxants have been divided into tizanidine, baclofen and benzodiazepines
- On the basis of diagnosis, the motor neurone disease (MND) market is segmented into blood tests, electromyography (EMG), MRI scan, transcranial magnetic stimulation (TMS) and others.
- On the basis of dosage, the motor neurone disease (MND) market is segmented into tablet, injection and others.
- On the basis of route of administration, the motor neurone disease (MND) market is segmented into oral, intravenous and others.
- On the basis of symptoms, the motor neurone disease (MND) market is segmented into muscle wasting, muscle weakness, fasciculations, speech problems, swallowing problems and excessive saliva, cramps and muscle spasms and others.
- On the basis of end-users, the motor neurone disease (MND) market is segmented into clinic, hospital and others.
The motor neurone disease (MND) market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Motor Neurone Disease (MND) Market Country Level Analysis
Motor neurone disease (MND) market is analyzed and market size information is provided by the country, type, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel as referenced above.
The countries covered in the motor neurone disease (MND) market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the motor neurone disease (MND) market due to the presence of major key players, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Motor neurone disease (MND) market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Motor Neurone Disease (MND) Market Share Analysis
Motor neurone disease (MND) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to motor neurone disease (MND) market research.
The major players covered in the motor neurone disease (MND) market report are Allergan, Merck Sharp & Dohme Corp., Pfizer Inc., GlaxoSmithKline plc, Abbott, F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Bayer AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, AbbVie Inc., Eli Lilly and Company, Bausch Health Companies Inc., UCB S.A., Sunovion Pharmaceuticals Inc., AstraZeneca, Takeda Pharmaceutical Company Limited., Sumitomo Dainippon Pharma Co., Ltd., Cipla Inc., Glenmark Pharmaceuticals Limited, Mankind Pharma, Novo Nordisk A/S, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-